Charles River Laboratories (CRL) — Strategic Asset Allocation Index
Charles River Laboratories (CRL) has a Strategic Asset Allocation Index of 7.0% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $209.72 Million) total $209.72 Million, measured against net assets of $2.99 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Charles River Laboratories liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Charles River Laboratories Strategic Asset Allocation Index (2000–2025)
This chart shows how Charles River Laboratories's Strategic Asset Allocation Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 7.0%, representing strategic assets of $209.72 Million against net assets of $2.99 Billion USD. See Charles River Laboratories (CRL) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Charles River Laboratories (2000–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Charles River Laboratories from 2000 to 2025, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Charles River Laboratories market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 69.2% | $2.22 Billion | $2.02 Billion | $206.97 Million | $3.21 Billion | ▲ +5.5 pp |
| 2024 | 63.7% | $2.23 Billion | $2.02 Billion | $218.35 Million | $3.51 Billion | ▲ +1.5 pp |
| 2023 | 62.2% | $2.28 Billion | $2.03 Billion | $243.81 Million | $3.66 Billion | ▼ -9.5 pp |
| 2022 | 71.7% | $2.17 Billion | $1.86 Billion | $311.60 Million | $3.02 Billion | ▲ +2.9 pp |
| 2021 | 68.9% | $1.79 Billion | $1.58 Billion | $201.35 Million | $2.59 Billion | ▲ +6.1 pp |
| 2020 | 62.8% | $1.35 Billion | $1.12 Billion | $221.80 Million | $2.14 Billion | ▼ -7.2 pp |
| 2019 | 70.0% | $1.17 Billion | $1.04 Billion | $122.98 Million | $1.67 Billion | ▼ -6.3 pp |
| 2018 | 76.3% | $1.02 Billion | $932.88 Million | $88.59 Million | $1.34 Billion | ▼ -3.8 pp |
| 2017 | 80.2% | $853.07 Million | $781.97 Million | $71.10 Million | $1.06 Billion | ▼ -13.7 pp |
| 2016 | 93.8% | $801.16 Million | $755.83 Million | $45.33 Million | $853.78 Million | ▲ +1.0 pp |
| 2015 | 92.8% | $710.69 Million | $677.96 Million | $32.73 Million | $765.56 Million | ▼ -7.1 pp |
| 2014 | 99.9% | $703.84 Million | $676.80 Million | $27.05 Million | $704.35 Million | ▼ -1.8 pp |
| 2013 | 101.7% | $676.18 Million | $676.18 Million | $- | $664.66 Million | ▼ -17.1 pp |
| 2012 | 118.9% | $717.02 Million | $717.02 Million | $- | $603.20 Million | ▼ -20.6 pp |
| 2011 | 139.5% | $738.03 Million | $738.03 Million | $- | $529.14 Million | ▲ +30.2 pp |
| 2010 | 109.3% | $752.66 Million | $752.66 Million | $- | $688.73 Million | ▲ +46.3 pp |
| 2009 | 63.0% | $865.74 Million | $865.74 Million | $- | $1.37 Billion | ▼ -6.1 pp |
| 2008 | 69.1% | $828.92 Million | $828.92 Million | $- | $1.20 Billion | ▲ +28.9 pp |
| 2007 | 40.2% | $748.79 Million | $748.79 Million | $- | $1.86 Billion | ▲ +6.8 pp |
| 2006 | 33.3% | $534.75 Million | $534.75 Million | $- | $1.60 Billion | ▲ +11.6 pp |
| 2005 | 21.7% | $399.45 Million | $399.45 Million | $- | $1.84 Billion | ▼ -2.3 pp |
| 2004 | 24.1% | $357.15 Million | $357.15 Million | $- | $1.48 Billion | ▼ -18.8 pp |
| 2003 | 42.9% | $203.46 Million | $203.46 Million | $- | $474.80 Million | ▼ -7.1 pp |
| 2002 | 50.0% | $187.88 Million | $187.88 Million | $- | $375.94 Million | ▼ -1.6 pp |
| 2001 | 51.5% | $155.92 Million | $155.92 Million | $- | $302.50 Million | ▼ -38.3 pp |
| 2000 | 89.8% | $117.00 Million | $117.00 Million | $- | $130.26 Million | — |